Position in OCGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$369,544
+$87,106 QoQ
Shares Held
204,168
-2.4% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Mitsubishi UFJ Asset Management Co., Ltd. holds $666,040,292 across 65 Biotechnology names. OCGN ranks #19 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
597,497 | $266,806,310 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
240,600 | $185,897,184 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
152,197 | $50,357,421 | |
| 4 | INSM |
INSMED Inc
|
255,247 | $41,737,989 | |
| 5 | INCY |
Incyte Corp
|
366,912 | $34,533,757 | |
| 6 | MRNA |
Moderna, Inc.
|
424,625 | $21,570,950 | |
| 7 | RPRX |
Royalty Pharma plc
|
442,778 | $21,240,060 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
164,988 | $16,045,083 |
All Filings in OCGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $369,544 | 204,168 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $282,438 | 209,214 | Shares | Defined | 2026-02-03 | |
| 2024-09-30 | $141,103 | 142,241 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $241,231 | 155,633 | Shares | Defined | 2024-08-13 | |
| 2023-03-31 | $143,750 | 168,523 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $202,944 | 156,111 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $200,476 | 112,627 | Shares | Defined | 2022-11-01 | |
| 2022-06-30 | $251,225 | 110,672 | Shares | Defined | 2022-08-04 | |
| No filing history on record for this holder in this stock. | ||||||